Abstract:Osteosarcoma, a malignant bone tumor predominantly affecting children and adolescents, presents significant therapeutic challenges, particularly in metastatic or recurrent cases. Conventional surgical and chemotherapeutic approaches have achieved partial therapeutic efficacy; however, the prognosis for long-term survival remains bleak. Recent studies have highlighted the imperative for a comprehensive exploration of the osteosarcoma immune microenvironment, focusing on the integration of diverse immunotherapeutic strategies—including immune checkpoint inhibitors, tumor microenvironment modulators, cytokine therapies, tumor antigen-specific interventions, cancer vaccines, cellular therapies, and antibody-based treatments—that are directly pertinent to modulating this intricate microenvironment. By targeting tumor cells, modulating the tumor microenvironment, and activating host immune responses, these innovative approaches have demonstrated substantial potential in enhancing the effectiveness of osteosarcoma treatments. Although most of these novel strategies are still in research or clinical trial phases, they have already demonstrated significant potential for individuals with osteosarcoma, suggesting the possibility of developing new, more personalized and effective treatment options. This review aims to provide a comprehensive overview of the current advancements in osteosarcoma immunotherapy, emphasizing the significance of integrating various immunotherapeutic methods to optimize therapeutic outcomes. Additionally, it underscores the imperative for subsequent research to further investigate the intricate interactions between the tumor microenvironment and the immune system, aiming to devise more effective treatment strategies. The present review comprehensively addresses the landscape of osteosarcoma immunotherapy, delineating crucial scientific concerns and clinical challenges, thereby outlining potential research directions.

Managing the immune microenvironment of osteosarcoma: the outlook for osteosarcoma treatment

The Role of CTLA-4 and PD-1 in Anti-Tumor Immune Response and Their Potential Efficacy Against Osteosarcoma

Advancements in osteosarcoma management: integrating immune microenvironment insights with immunotherapeutic strategies

Immune Microenvironment in Osteosarcoma: Components, Therapeutic Strategies and Clinical Applications

Advances on immunotherapy for osteosarcoma

Immunotherapy Innovations in the Fight against Osteosarcoma: Emerging Strategies and Promising Progress

Novel Immunotherapies for Osteosarcoma

Immunotherapy for osteosarcoma: Fundamental mechanism, rationale, and recent breakthroughs

Recent Advances in Nanoplatforms for the Treatment of Osteosarcoma

Effects of microenvironment in osteosarcoma on chemoresistance and the promise of immunotherapy as an osteosarcoma therapeutic modality

Unraveling molecular aberrations and pioneering therapeutic strategies in osteosarcoma

Current Status and Prospects of Immunotherapy for Osteosarcoma

Osteosarcoma and Metastasis

T-Cell-Based Immunotherapy for Osteosarcoma: Challenges and Opportunities.

Modulation of immunosuppressive cells and noncoding RNAs as immunotherapy in osteosarcoma

Macrophages in Osteosarcoma Immune Microenvironment: Implications for Immunotherapy

Molecular Pathogenesis and Therapeutic Strategies of Human Osteosarcoma

Biomaterials‐Boosted Immunotherapy for Osteosarcoma

Innate Immune Cells: A Potential and Promising Cell Population for Treating Osteosarcoma

Molecular targeted therapy of osteosarcoma and related clinical

Immune Checkpoints in Osteosarcoma: Recent Advances and Therapeutic Potential.